Aigen Investment Management’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Aigen Investment Management’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-35,601	Closed	-$112K	–	1234
2021 Q4	$112K	Buy	+35,601	New	+$120K	0.01%	988
2020 Q3	–	Sell	-45,583	Closed	-$199K	–	1209
2020 Q2	$199K	Sell	45,583 -114,674	-72%	-$515K	0.03%	717
2020 Q1	$607K	Buy	160,257 +156,014	+3,677%	+$767K	0.08%	367
2019 Q4	$27K	Buy	+4,243	New	+$24.9K	﹤0.01%	884

Other funds holding BDSI

CAM

Close Asset Management London, United Kingdom $3.69B AUM 21.62% 1-Year Est. Return

FCMT

Founders Capital Management (Texas) Houston, Texas $231M AUM 61.68% 1-Year Est. Return

Aigen Investment Management's BDSI Position: Q1 2022 in Review

Aigen Investment Management sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 35,601 shares — an estimated $112K sold.

Aigen Investment Management first reported a position in BDSI in Q4 2019 and held it in 4 quarters. The position peaked at $607K in Q1 2020. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

Aigen Investment Management reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
Aigen Investment Management sold 35,601 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $112K.
Aigen Investment Management first reported a position in BioDelivery Sciences International, Inc. in Q4 2019 and held it in 4 quarters.
Aigen Investment Management's BioDelivery Sciences International, Inc. position peaked at $607K in Q1 2020.
2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on Aigen Investment Management's 13F filing for Q1 2022, filed 5 May 2022.